**Core tip:** Cricopharyngeal dysphagia can be treated with endoscopic balloon dilatation. In this series, a novel dilatation technique of pulling a fully inflated 15-20 mm balloon dilator in a retrograde manner across the upper esophageal sphincter was safe and effective for the treatment of cricopharyngeal dysphagia.

INTRODUCTION
============

The upper esophageal sphincter, comprised of the cricopharyngeus, or the cricopharyngeal (CP) muscle, inferior pharyngeal constrictor, and proximal cervical esophagus serves a pivotal role in the act of deglutition. The CP muscle normally remains in a contracted state and relaxes during swallowing prior to penetration of a food bolus into the cricopharyngeal region. Cricopharyngeal dysfunction (CPD) refers to incoordination of the cricophyngeal muscle either due to a primary functional disorder or as a result of an underlying neurological or medical condition\[[@B1]\]. Symptoms of CPD can range from a globus sensation to oropharyngeal dysphagia manifested by regurgitation, coughing, choking and recurrent aspiration.

The diagnosis of CPD can be difficult to make and often requires a meticulous history and physical examination. Videofluoroscopy is often helpful for the diagnosis of CPD with the typical appearance of a shelf in the posterior column of barium at the level of the cricoid cartilage, more commonly described as a cricopharyngeal bar\[[@B2]\]. The incidence of CP bars is variable in the reported literature, ranging from 5% to 22% in patients who undergo videofluoroscopic swallow studies for dysphagia\[[@B2]-[@B4]\]. CP bars are frequently detected in asymptomatic individuals and therefore other modalities such as esophageal manometry and upper endoscopy must be performed to exclude other etiologies of dysphagia.

Endoscopic treatment for CPD has not been well studied and remains controversial. Historically, management has relied upon surgical CP myotomy\[[@B5]-[@B7]\]. Endoscopic dilatation poses an attractive option, given the risks associated with myotomy; however, published case series to date have included very small numbers of patients with varying dilatation techniques\[[@B8]-[@B13]\]. The aim of our study was to determine the efficacy and safety of through-the-scope (TTS) balloon dilatation of the upper esophageal sphincter (UES) in patients with CPD and to compare the traditional static technique of sequential distention of the balloon with a brusque "pull-back" retrograde approach across the UES.

MATERIALS AND METHODS
=====================

The study was approved by the Johns Hopkins Medicine institutional review board. The medical records of all patients that underwent esophageal dilatation with a through-the-scope balloon dilator at the Johns Hopkins Hospital over a consecutive 3-year period were reviewed. Patients were included in the study cohort if they had CPD that was treated with TTS balloon dilatation of the UES, including those with a Zenker's diverticulum. Patients were excluded if they were under the age of 18 years old and if balloon dilatation of the UES was not performed. Patient demographics, prior radiographic data, procedural indications, test results, complications and follow-up clinical outcomes were recorded.

Data was analyzed using Stata version 9 (StataCorp, College Station, TX) on a per-patient basis. Descriptive statistics were calculated for all covariates and outcomes including *t* test, *χ*^2^ test, and Fisher's exact test, where appropriate.

Procedural technique
--------------------

Balloon dilatation of the upper esophageal sphincter was performed using two different techniques: Static and retrograde. With the traditional "static" technique, a through-the scope balloon dilation catheter (Boston Scientific Corporation, Natick, MA) is positioned across the upper esophageal sphincter under visual guidance without the use of a guidewire or fluoroscopy. The balloon is then sequentially inflated, holding the balloon in position for 30 to 60 s with each distention to a maximum diameter of 15 mm to 20 mm at the discretion of the endoscopist.

The retrograde approach across the UES is a newly described technique for the management of CPD. The actual technique has been used for mucosal disruption and treatment of esophageal rings, but has not been described in the management of CPD\[[@B14]\]. In this approach, the TTS balloon is inflated to the maximal desired diameter under visual guidance in the proximal esophagus, distal to the UES. The fully distended balloon is then brought back to the tip of the endoscope. Both the endoscope and distended balloon are then withdrawn across the UES into the oropharynx as one unit, usually with moderate resistance.

In all cases, individuals were sedated for the procedure. After dilatation was performed, the UES and the surrounding structures were closely inspected for evidence of mucosal damage.

RESULTS
=======

Over a consecutive three-year period 488 esophageal TTS balloon dilatations were performed at our institution, of which 31 patients had dilatation of the UES for CPD. The median age at time of UES dilatation was 63 years and 55% of the patients were male (Table [1](#T1){ref-type="table"}). Indications for UES dilatation are summarized in Table [1](#T1){ref-type="table"}. Twenty-eight patients (90%) were experiencing dysphagia symptoms. In addition to CPD, 16 patients (52%) had evidence of concurrent oropharyngeal dysfunction and 7 patients (23%) were also found to have a Zenker's diverticulum.

###### 

Patient demographics *n* (%)

  **Patients undergoing UES dilatation**                                          ***n* = 31**
  ------------------------------------------------------------------------------- --------------
  Age, yr, median (range)                                                         63 (27-81)
  Sex                                                                             
  Male                                                                            17 (55)
  Female                                                                          14 (45)
  Indications                                                                     
  Radiographic CP hypertrophy with dysphagia                                      22 (71)
  Endoscopic UES tightness with dysphagia                                         3 (10)
  Inclusion body myositis with dysphagia and prominent cricopharyngeus            3 (10)
  Globus sensation with evidence of UES dysfunction                               2 (6)
  Obstruction to echocardiography probe with CP bar, but otherwise asymptomatic   1 (3)
  Presence of oropharyngeal dysfunction                                           16 (52)
  Presence of Zenker's diverticulum                                               7 (23)

UES: Upper esophageal sphincter; CP: Cricopharyngeal.

Each individual underwent a median of 1 dilatation (range, 1-3), with 24 individuals (77%) receiving a retrograde approach (Table [2](#T2){ref-type="table"}). The majority of individuals (26) underwent only 1 dilatation session. Four individuals underwent two dilatation sessions and one patient had three dilatation sessions. Eleven individuals had dilatation of other esophageal segments concurrently with UES dilatation and 20 patients had UES dilatation alone. Of those with multiple sites of esophageal dilatation, nine were for a Schatzki ring, one was for a peptic stricture and one was for subjective stenosis at the esophagogastric junction. The median maximal diameter for UES balloon dilatation was 20 mm, ranging from 15 to 20 mm. Three individuals were dilated with a 15 mm balloon, nine individuals were dilated with an 18 mm balloon, and nineteen individuals were dilated with a 20 mm balloon.

###### 

Balloon dilatation procedural details *n* (%)

                                                                         **Enrolled (*n* = 31)**
  ---------------------------------------------------------------------- -------------------------
  Number of procedures per patient, median (range)                       1 (1-3)
  Type of initial dilatation                                             
  Retrograde (brusque pull-back)                                         24 (77)
  Static (sequential distention)                                         7 (23)
  UES dilatation alone                                                   20 (65)
  Concurrent dilatation of the UES and other portions of the esophagus   11 (35)
  Maximal diameter size, median (range)                                  20 mm (15-20 mm)
  Total Number of complications                                          1 (3)
  Serious complications requiring hospitalization                        0

UES: Upper esophageal sphincter.

Follow-up was available for 24 of the 31 patients, 19 of whom underwent retrograde brusque technique. The median duration of follow-up was 2.5 mo (interquartile range: 1-10 mo), of whom 19 (79%) reported symptomatic improvement. Sixteen patients (84%) patients with the retrograde approach responded to dilatation, whereas 3 patients (60%) with the static dilatation approach responded to treatment. However, there was no statistically significant difference in symptom improvement between the two techniques (*P* = 0.5). Successful symptom resolution was also not significantly affected by dilator size, presence of oropharyngeal dysfunction, presence of a Zenker's diverticulum, age or gender (Table [3](#T3){ref-type="table"}). Of those patients undergoing UES dilatation alone, follow-up was available for 15 patients, 12 of whom (80%) reported symptom improvement.

###### 

Predictors of clinical response *n* (%)

  **Characteristic**                     **Clinical response**   ***P* value**   
  -------------------------------------- ----------------------- --------------- ------
  Age, mean ± SD                         61.9 ± 11.9             66.4 ± 22.4     0.48
  Sex, Male                              10 (53)                 2 (40)          0.68
  Technique                                                                      
  Retrograde                             16                      3               0.49
  Static                                 3                       2               
  Maximal dilator size (mean ± SD, mm)   19.2 ± 1.4              19.6 ± 0.9      0.25
  Oropharyngeal dysfunction              11 (58)                 2 (40)          0.68
  Zenker's diverticulum                  4 (21)                  2 (40)          0.45

One patient developed uvular edema and a shallow ulcer after static dilatation of the UES that spontaneously resolved in the recovery room and did not require hospitalization. A second patient initially underwent dilatation of the GE junction that resulted in a small mucosal tear that was adequately treated with placement of a single endoclip. During the same endoscopy, subsequent to endoclip placement, the patient underwent retrograde dilatation of the UES without complication. There were no adverse events associated with the retrograde brusque technique of the UES.

DISCUSSION
==========

Oropharyngeal dysphagia can be associated with significant morbidity and treatments to date are imperfect and limited. Since first used for treatment of post-poliomyelitis dysphagia in 1951\[[@B15]\], surgical myotomy has been the traditional approach for dysphagia related to cricopharyngeal prominence or dysfunction\[[@B16]-[@B18]\]. However, efficacy remains controversial and this procedure is not without risk - particularly in elderly patients in whom cricopharyngeal bars are more common\[[@B18]-[@B20]\]. Botulinum toxin injection has also been studied as a potential therapy and has been shown to be of benefit in several series\[[@B21]-[@B23]\]. Reported complications have stemmed from diffusion of Botox to adjacent muscles leading to aspiration, worsened dysphagia, vocal cord paralysis and at least one recorded death\[[@B24]-[@B26]\]. Moreover, the average duration of effect appears to be approximately 4 mo and waning efficacy may be observed with repeated therapy\[[@B25]\].

Endoscopic dilatation of the upper esophageal sphincter poses an attractive therapeutic alternative for dysphagia related to CPD. Data, however, is limited to small case series - most of which contained less than 10 patients. The published data suggest that endoscopic dilatation may be a safe and effective option for carefully selected patients. A small series reported clinical improvement in 7 of 12 patients (58%) after dilatation with a Savary dilator (17 mm)\[[@B8]\]. Another limited series reported higher rates of symptomatic improvement in 9 of 10 patients (90%) with similar dilatation techniques (18-20 mm)\[[@B9]\]. Patel et al\[[@B13]\] recently reported a larger experience with 31 patients undergoing Savary dilation with 45 French to 60 French size dilators. In this study, 65% of patients had significant improvement for at least 6 mo using a functional outcome swallow score.

One study of 5 patients undergoing static balloon dilation of the UES to a maximal diameter of 20 mm achieved 100% success rate\[[@B10]\]. Another study reported complete success in 6 patients undergoing dilatation of CP bars, but this study only included one patient with balloon dilation to 20 mm and the five others underwent Savary dilation\[[@B12]\]. In these series and reports, there have been no recorded major complications. There has been one report of superficial mucosal injury after dilatation that was self-limited and did not require treatment or hospitalization\[[@B10]\]. The recent systematic review on management of CPD reported comparable success rates of endoscopic dilation and myotomy; however, the authors comment that there were significantly fewer studies investigating endoscopic dilatation (6 studies involving 113 patients) and therefore the data were insufficient to make a strong recommendation on the role of endoscopic dilatation for CPD\[[@B1]\].

Our series represents the largest published series to date looking at endoscopic balloon dilatation of the upper esophageal sphincter for dysphagia related to CPD. When compared to reported success rates for cricopharyngeal myotomy\[[@B18],[@B20]\], the results for endoscopic dilatation appear equivalent. Moreover, the safety profile of this approach appears to be excellent. In our series, the only reported complication was uvular edema and a shallow ulcer after balloon dilatation using a static technique in 1 patient that did not require admission and spontaneously improved over time. To our knowledge, there have been no perforations reported in the literature with this approach and certainly no fatalities.

At our institution, the preference has been to utilize endoscopic balloon dilatation *via* either a static or retrograde technique for CPD. The idea behind the static approach is to maximize radial forces while avoiding any sheering movements, whereas the concept for the retrograde approach is to combine radial and sheering forces with directed attention to the upper esophageal sphincter. As opposed to a Savary dilatation, the retrograde balloon technique may allow a more rapid increase in diameter and, with experience, a better subjective gauge of sphincter resistance. To our knowledge, this technique has not been previously reported in the literature for the management of CPD but has been used frequently at our institution for disruption of Schatzki rings, mucosal webs and upper esophageal sphincter dysfunction. While the safety of this approach has not been directly compared to conventional static dilatation, it has been our subjective opinion that the safety of these two approaches is equivalent. The one patient who developed a shallow ulcer in our series did so in the context of a static dilatation.

Traditionally, the presence of a Zenker's diverticulum has often been felt to represent a relative contraindication to endoscopic dilatation; however, mechanistically, these diverticula often arise in the context of elevated intrabolus pressure and/or upper esophageal sphincter dysfunction and for this reason may actually portend a better prognosis\[[@B27]\]. Certainly in our series, response rates seemed equivalent between patients with and without a diverticulum and there did not appear to be any safety concerns. Likewise, oropharyngeal dysfunction has been hypothesized to be a potential issue that may limit efficacy. However, this group may actually be more sensitive to minor mechanical alterations in outflow resistance and the presence of oropharyngeal dysfunction in our series did not affect or predict response.

Our study does have several limitations worth noting. To begin with, it is a retrospective evaluation and clinical response was determined subjectively through review of medical records. A prospective study with validated dysphagia questionnaires would have been ideal and this certainly is worth future consideration. Second, 11 of our patients had dilatation of other esophageal segments other than the upper esophageal sphincter and it is unclear if the symptom response was due to dilatation of the cricopharyngeus or the other segment of the esophagus. However, even without including these patients, this remains the largest published experience with endoscopic balloon dilatation for CPD. Third, the indications for dilatation in our series were heterogeneous and it is possible (and indeed likely) that certain subsets have significantly varied responses. For example, it is our subjective opinion that patients with inclusion body myositis likely have a greater response to dilatation; however, given the total number of patients in our study there is no way to statistically address that question. Finally, our median follow-up was 2.5 mo and given the underlying mechanisms of upper esophageal sphincter dysfunction a longer evaluation period would have been ideal.

In summary, UES dilatation with a TTS balloon by either static or retrograde technique is safe and effective for the treatment of dysphagia in the context of CP dysfunction. As suggested in prior smaller series, this appears to be a safe and effective approach. Our series, however, is the first to describe retrograde balloon dilatation of the UES. Given this data is tandem with the reported complications of surgical myotomy and Botulinum toxin injection, we suggest that endoscopic dilatation of the upper esophageal sphincter should be the first therapy offered for patients with oropharyngeal dysphagia in the context of upper esophageal sphincter dysfunction. In addition, our experience would suggest that balloon dilatation *via* a retrograde technique is at least as safe and effective as conventional methods with either Savary or static balloon dilatation.

COMMENTS
========

Background
----------

Cricopharyngeal dysfunction (CPD) is associated with a variety of symptoms including globus sensation, oropharyngeal dysphagia, regurgitation, coughing, choking and recurrent aspiration. While a variety of treatment options have been proposed, endoscopic dilatation by pulling a fully inflated 15-20 mm balloon dilator in a retrograde manner across the upper esophageal sphincter appears to be safe and effective for the treatment of cricopharyngeal dysphagia.

Research frontiers
------------------

Optimal management of cricopharyngeal dysphagia is not clear. Endoscopic dilatation appears to be safe with immediate relief of symptoms. Several small series have demonstrated benefit with endoscopic dilatation using a variety of techniques. Additional research into the durability of the procedure and objective parameters of relief are needed.

Innovations and breakthroughs
-----------------------------

This represents the largest endoscopic experience for managing CPD. In this series, a novel dilatation technique of pulling a fully inflated 15-20 mm balloon dilator in a retrograde manner across the upper esophageal sphincter was safe and effective for the treatment of cricopharyngeal dysphagia.

Applications
------------

The retrograde dilatation technique provides another method for effective dilatation and disruption of the upper esophageal sphincter complex to relieve symptoms associated with cricopharyngeal dysphagia. Many endoscopists are more comfortable with balloon dilatation and this technique may allow them to better treat CPD using this technique.

Terminology
-----------

CPD - refers to incoordination of the cricophyngeal muscle either due to a primary functional disorder or as a result of an underlying neurological or medical condition.

Peer-review
-----------

This is a study assessing the efficacy of endoscopic balloon catheter dilatation for treatment of criocopharyngeal dysfunction. The authors retrospectively reviewed all UES dilatations performed during a three year period. Thirty-one patients were included although follow-up was only available for 24. A symptomatic improvement was confirmed for 80% of patients. The manuscript is well written and describes a large series of cases.
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